Silva Álvaro Siqueira, Duprat André Campos, Machado Súnia Ribeiro, Melo Daniele Nahmias, Nascimento Ribeiro Dayse Kelle
Amazonas State University, Manaus, AM, Brazil.
Otorhinolaryngology Department, Medical Sciences College, Santa Casa de São Paulo, São Paulo, SP, Brazil.
Int Arch Otorhinolaryngol. 2021 Jan;25(1):e115-e122. doi: 10.1055/s-0040-1702967. Epub 2020 May 4.
Laryngopharyngeal reflux (LPR) is a prevalent condition in outpatients visiting the otorhinolaryngological clinic, with many controversies regarding its diagnosis and follow-up. Therefore, there is a need for clinical instruments that can diagnose individuals and monitor the results of their treatment. To evaluate the applicability of the scores translated and adapted to Brazilian Portuguese: Reflux Symptom Index (RSI) and Endolaryngeal Reflux Findings Scale (ERFS), as instruments for post-treatment follow-up of LPR. A total of 35 individuals with atypical symptoms of gastroesophageal reflux disease and with an objective diagnosis of LPR, confirmed by high digestive endoscopy and 24-hour esophageal pH-metry dual probe test were submitted to the RSI and ERFS questionnaires, used in the pre- and post-treatment of 90 days with a Proton Pump Inhibitor. The evaluation of RSI and ERFS in the pre- and post-treatment showed a reduction in the results of the two scores, with a higher drop in the RSI ( < 0.001) than in the ERFS ( = 0.014). Although there was an improvement in the values in 23.9% of the individuals in the ERFS, there was no change in the category ( = 0.057), different from the RSI ( < 0.001), where there was a 67.4% improvement in values, as well as change in category (score went from positive to negative). There was a correlation between RSI and ERFS, moderate in the pretreatment and strong in the post-treatment. The RSI and ERFS scores, when translated and adapted for Brazilian Portuguese and applied simultaneously, can be considered a good tool for post-treatment LPR follow-up.
喉咽反流(LPR)在耳鼻喉科门诊患者中是一种常见病症,其诊断和随访存在诸多争议。因此,需要能够诊断个体并监测其治疗结果的临床工具。
反流症状指数(RSI)和喉内反流发现量表(ERFS)作为LPR治疗后随访工具的适用性。
共有35名有胃食管反流病非典型症状且经高分辨率消化内镜检查和24小时食管pH双探头测试确诊为LPR的个体,接受了RSI和ERFS问卷调查,在使用质子泵抑制剂进行90天的治疗前和治疗后使用。
治疗前和治疗后对RSI和ERFS的评估显示,两个评分结果均有所降低,RSI的降幅更高(<0.001),高于ERFS(=0.014)。尽管ERFS中有23.9%的个体数值有所改善,但类别没有变化(=0.057),这与RSI不同(<0.001),RSI数值改善了67.4%,且类别也发生了变化(评分从阳性变为阴性)。RSI和ERFS之间存在相关性,治疗前为中度,治疗后为强相关。
RSI和ERFS评分在翻译并改编为巴西葡萄牙语并同时应用时,可被视为LPR治疗后随访的良好工具。